FDA Inspection 1200649 — ImpactLife
The FDA completed an inspection of ImpactLife on March 22, 2023 in Dubuque, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dubuque, IA (United States)